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ABSTRACT

Real-Time Detection of Cravings in Individuals with Substance
Abuse using Wearable Biosensors and Machine Learning
KEERTHI KUMAR CHINTHA
Thesis Chair: Premananda Indic, Ph.D.
The University of Texas at Tyler
May 2018

Deaths in the US have drastically increased over the past decade due to addictive behaviors and
drugs. According to the World Health Organization (WHO), 1 in 20 adults between the age of 15
and 64 years are addicted to at least one illicit drug; globally, 29 million people are suffering from
drug use disorder. The addiction of narcotics alters a person’s primary function as well as critical
areas of the brain due to multiple reasons like genetics, hereditary, stress or pressure, and mental
health conditions. It not only affects an individual but also their families. Intensive research has
been launched all over the world to spread awareness about how to prevent addiction. The current
problem for efficiently managing and treating these addicted individuals is the lack of biomarker
for detecting cravings. If clinicians could identify cravings in individuals, they might able to design
appropriate intervention strategies, including mobile based mindfulness techniques, dialectical
behavioral therapy (DBT) based exercises, or direct contact with support persons to mitigate risky
situations (cravings) that could otherwise result in relapse. In our work, we explored the possibility
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of employing wearable biosensors along with machine learning approaches to define a reliable
biomarker of craving.
In this work, participants wore wrist-mounted biosensors on their non-dominant arm for
all waking hours for a four-day period. An event marker was used to denote any time they
perceived drug craving. For analysis, raw accelerometer data in three axes (x, y, and z) evaluated
20 minutes before and 20 minutes after each marked event. A sliding window technique with
signal processing Hilbert transformation approach was applied to extract relevant features mean,
variance, shape, scale, and 𝐷𝑘 (a distance measure derived using six parameters in a hypothetical
six-dimensional space). These features employed in machine learning approach with two different
quadratic (non-linear) models to detect cravings. The collaborative work of two machine learning
models provided us an accuracy of 72% in the detection of cravings.
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CHAPTER ONE
INTRODUCTION
Addiction to drugs has become a global issue. Every country in the world is trying to create
awareness about drug addiction by creating forums and, global meetings. According to US
National Institute of Health, more than 64,000 Americans die yearly due to a drug overdose, a 3.5
percent increase in the death rate in two decades. Addiction should be treated at an initial stage to
prevent the inevitable fatal consequences.
Addiction is a chronic, relapsing disorder which can include compulsive drug craving. It is also
named as a brain disease as it changes the brain structure and its function. It disrupts the standard
functionality of the underlying organs like brain, heart, lungs and kidneys. The changes can be
long-lasting. As it progresses, it becomes ones’ daily life. Its effect seen in all age groups and even
the babies in their mother’s womb.

1.1 Reasons for addiction
Addiction is a complex mental condition that can be due to multiple reasons such as
environmental, biological and developmental factors. Some of these include:
•

Genetics
Addiction depends on genetic factors [1], however it can be overcome with personal
choices (for example “will power”). Research shows that the susceptibility of a person to
addiction is strongly influenced by genetics. According to National Institute on Drug Abuse
estimates, 40-60 percent of developing addiction is based on genetics. Further, research is
in process to understand contribution of genetics to addiction.
1

•

Environment
If there is anyone in the family has a history of drug or alcohol abuse, then it has an impact
on their younger generation, consciously or subconsciously and they develop a drug or
alcohol problem. Hereditary can also happen based on the environment they live in and the
time, with whom they spend most outside the family, that may lead to a mental health
disorder [1].

•

Stress or Pressure
The person gets accustomed to the alcohol or drugs, to get rid of pain due to stress like a
deadline given by the company manager or something like a competitive exam. At the
initial stage, the small amount of alcohol or drugs will make him feel like nurture from that
pain and later gets used to amount or quantity the individual is taking, and the body begins
responding less to that amount. As a result, they try to increase its amount little by little
and reaches a point where it becomes an addiction [1].

1.2 Stages of addiction
Here we discuss different stages of addiction based on complicated mix of genetics
and environmental factors determine if a person is at greater risk for addiction [2].
•

Stage One
During this stage, the addict will have the illusion of pleasurable mood and comfort. The
addict develops sense of personal power. By this, the individual will avoid unpleasant
situations. Once the effect of the drug is gone, the person starts to feel the pain or
uncomfortable situation again and like to have drug again. This cycle continues, and the
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person becomes an addict. This emotional craving results in the mental preoccupation with
drug and ends in addictive behavior.
•

Stage Two
This is the intermediate stage; the addict surrenders to the power of addiction. The person
becomes more preoccupied with drugs and makes drugs as a lifestyle. As a result, it
becomes noticeable to the people around them. This behavior makes them isolated from
others and strengthens the addictive process. This is the sign of the start of problems, people
recognize addicts as strange, irresponsible and prone to be troublemakers. The addict
becomes intolerant and impatient during this stage for which he craves drug more
frequently and in dangerous ways. By the end of this stage, they drain more of their energy
to maintain their balance with the internal emotions, thus limiting their ability to lead a
healthy life.

•

Stage Three
The stage three is the final stage, where the addict is entirely under the control of addiction.
During this stage, the intoxication begins to break down, and never-ending pain returns.
The addict frequently displays anger, depression, guilt, loneliness, and hopelessness. Some
of these individuals either die of suicide or accidental drug overdose. The remaining
individuals continue to struggle to overcome addiction and some may eventually seek
treatment for recovery.

3

1.3 Treatment and recovery
•

Cognitive Behavioral Therapy (CBT)
This therapy helps the addict to recognize, avoid and understand the situations, which may
lead to drug abuse. CBT has shown positive results by addressing unhealthy thought
patterns and replacing them with the new and healthy ones.

•

Contingency Management
The addict is encouraged to attend the counseling sessions or take medications as
prescribed. In this method, rewards or privileges to make the addict feel good. This therapy
consists of methadone programs and psychosocial counseling treatment programs.

•

Motivational Enhancement Therapy
In this session, therapists or counselors help the addict to get motivated to get rid of the
drug by facilitating required treatment like giving examples of life threating experiences as
well as providing the virtual environment to understand the pain.

•

Family Therapy
In this therapy, therapists or counselors approach the addicts drug problem with the help
of family interactions and educate the addict about other risky behaviors. Family therapy
helped both adults and adolescents. In this therapy, they engage families in applying the
behavioral strategies during their sessions.

1.4 Cravings
Although understanding addiction and drug abuse are essential, one critical factor that
might help clinicians to intervene effectively is to detect cravings. We focused our attention on
understanding cravings and possibly a method for screening. We defined craving for the
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participants as a strongest desire for something. Our participants were instructed to identify a
craving event (and press the event marker) anytime they felt a strong urge to use their drug of
choice and stress as a period of significant psychological distress. We left the threshold for pressing
the button to indicate and event somewhat open- we told them to indicate events that were
significant to them. The other factors which are related to craving are interlinked either directly or
indirectly; for instance, smoking, reckless behavior to seek pleasure and drug abuse. The desire
for food is entirely dependent on limbic systems and prefrontal cortex. Any needs may eventually
lead to hopelessness and reduced quality of life. Hence it is essential to know the basic functioning
of a craving to guide better clinical management of the underlying condition. A research study
shows that limbic systems and prefrontal cortex regions are involved in alcohol addiction. Also,
the neurobiology of addiction depends on personal preferences for low or high-risk life styles [3].
In this project we designed a machine learning algorithm which can be embedded into the
wearable biosensors that can detect cravings by analyzing the activity data obtained from
individual subjects.
To reliably identify the features from the data that can be used in machine learning
algorithms, we studied the changes in the biosensor data when the individuals consumed an opioid
drug. Then, we examined the changes in the biosensor profile data during opioid overdose and
subsequent removal of the drug using an antidote (Naloxone). These studies conducted to
understand the significant changes that might occur in the features derived from the biosensor data.
Identifying reliable features that can respond to changes when an opioid is in the human body as
well as subsequent changes when the drug is undergoing withdrawal from the system is very
important for designing a machine learning model. After studying the changes in the features, we
employed these features to build a machine learning algorithm for detecting cravings.
5

In chapter 2, we review previous background works which relate to our study. Chapter 3,
provides details of different methods we used in our work, such as the Hilbert transform, nonlinear Support Vector Machine (SVM), and discriminant. Chapter 4 provides details about
algorithm implementation and results obtained during our work. Finally, Chapter 5 gives
conclusion and future study.
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CHAPTER TWO
BACKGROUND
In this chapter, we will briefly review previous research which was conducted to detect or
reduce the number of deaths due to addiction, stress, cravings, smoking, and alcohol abuse. Also
presented, is a detailed explanation of methods implemented in their papers and their results, and
limitations.
Recent statistics from Center for Disease Control/National Institute on Occupational Safety
and Health (NIOSH) showed that the workplace is the leading cause of life stress. Nearly 110
million people die every year as a direct result of stress. Among them, over thirty thousand people
died due to the opioid epidemic [4]. To attenuate the count of deaths every year the research on
this issue has seized the utmost priority.
To follow the biometric profile of an individual with an opioid in the system and opioid
withdrawal from the system, we studied the biosensor profile, with drug administration and with
naloxone as an antidote, for opioid overdose. Naloxone blocks the opiate receptors and reverses
the toxic effects of opioids like respiratory depression after the drug overdose. It does not have an
impact for a long time; the drug effect varies from 30-90 minutes [5]. When compared to the
opioid, the antidote does not last much longer than the opioid that initially caused the overdose
[6,7]. The patients who received the cure as overdose must be transported to the hospital for further
observation to make sure that the opioid toxicity does not relapse, once the effect of the drug is
done [8]. If patients are reluctant to return to the hospital, then opioid toxicity re-occurrence may
have devastating consequences.
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Since there were not many works done using wearable bio-sensors for the detection of
cravings, we focused on other areas such as alcohol, drugs (opioid and naloxone), cigarette and its
relapse, due to craving. In recent years, Fletcher et al. [9] used a wearable sensor platform and
mobile application for use in Cognitive Behavioral Therapy for detection of drug addiction and
post-traumatic stress disorder (PTSD). In their paper, they used the wearable sensor for studying
autonomic nervous system (ANS) for mental health treatment and interventions. This study
utilized two different sensors; a custom-designed electrocardiogram (ECG) monitor worn on the
chest and the sensor band on the ankle which continuously monitors electrodermal activity (EDA).
They were connected via Bluetooth to a mobile device to monitor the electrocardiogram (ECG).
When a specific arousal event is detected, the mobile phone presented therapeutic and empathetic
messages to the patient in the tradition of cognitive behavioral therapy (CBT). At the initial stage
of work, their method was able to measure the person’s mood or stress and helped the subjects to
cope with episodes of cravings and understood the addiction or anxiety due to mental health
disorder [9].
In another work, Bae et al. [10] implemented alcohol control utilizing mobile phones builtin sensors (e.g., accelerometer, location) and meta-data (e.g., communication logs) to detect and
monitor behavioral patterns related to the initiation of drinking. A machine learning technique was
created, by combining the collected data from these sensors and the use of Experience Sampling
Method (ESM) to collect self-reports of alcohol use, the sample size was 30 young adults between
21-28 years for 28 consecutive days. Each day ESM report was found to be the most precise
method to summarize the self-reports of drinking episodes instead of reporting at the end of the
day or just after the events as the participants would usually ignore or forget to say. A daily survey
would ask the participants the fundamental questions which would then be used to generate a
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report. This machine learning-based technique they proposed provided a 96.6% accuracy for
identifying drinking, non-drinking and drinking episodes. Disadvantages of using this method are
the occasional device failure, a decrease in compliance of the subjects towards self-reporting
decreased towards the end of the study due to voluntary shutoff of the mobile in case of battery
drain or towards non-compliance to the test thus severely altering the official research results [10].
In another paper, Gupta et al. [11] used an interesting approach to reduce addiction to
nicotine, marijuana and other addiction sources using Virtual Reality (VR) in the medical field. In
their method, they used VR computer simulated environment where it creates experiences like the
virtual taste, sight, smell, sound, and touch. In addition to that, they created gaming applications
to understand the limitations of the person in different situations. The main idea of their project
was to create fear in the person to reduce his/her addiction by giving them real-life pain or stress
caused by addiction in the virtual world. This approach does not create any physical harm to the
addict, but it gave him/her experiences of addiction [11].
Timms et al. [12] in their paper discussed control of smoking using a hybrid model
predictive control (HMPC) strategy. In their analysis, 400 participants had given self-reports
through a mobile technology during their smoking cessation clinical trial [12,13]. In their study,
an intervention algorithm was developed, consisting of counseling and pharmacotherapies
manipulated to reduce smoking and craving. By this method, they found suppressing of relapse
and found time-varying stress. Although the success rate was not high, their model shows; decision
framework adjusts counseling, bupropion (Zyban, GlaxoSmithKline) and lozenge (nicotine) doses
over time by which craving levels were reduced [14]. In other research, basket et al. [15], they
relied on questionnaires and interviews with examiners. This paper highly directed towards a
smartphone-based wireless body area sensing system provides real-time interventions consisting
9

of several wearable sensors for measuring physiological data, a smartphone, and a web server
together gave the accuracy of 90% [15].
Chatterjee et al. [16], explained that craving plays an essential role in the relapse phase of
addiction. A craving estimation model known as mCrave, based on a linear-chain Conditional
Random Fields (CRF) model, can continuously infer probability of strong craving for an entire
day continuously every minute. CRF helps to make subsets of data on a minute by minute basis to
determine desire and non-craving patterns. This model was created to eliminate recall-bias and
noncompliance of participants in self-reporting experiments. The graphical model was used to
determine the probability distributions involving inter-dependent random variables, by
constructing the linear separating boundary between times of low and high craving. This model
established a relationship of craving likelihood being inversely proportional to the probability of
stress at that minute. The ROC curve was observed to find the performance of model being better
for periods of high vulnerable hours than low vulnerable hours. The craving estimation for the
likelihood of stress had an accuracy of 72.9% and kappa (κ) 0.429 [16].
All the previous research is related to the subjective detection of craving in patients
with addiction (i.e. self-report by the addicts by pressing the button on the bio-sensor) and
subsequent interventions. Our stay is novel in that it seeks to define an objective measure of drug
craving, which can be detected automatically and serve as a trigger for key interventions.

2.1 Wearable sensors with accelerometer
In present days, we cannot imagine life without technology and wearable sensors; They are
becoming more prevalent due to their application in the medical field. Sensors help the addicts and
clinicians by providing continuous feedback like calories burned and hours of sleep activity.
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Sensors also monitors physiological signals, temperature, heart rate, blood pressure volume and
skin temperature. Complexity in the selection of the smartwatch and its application has increased,
as there are more than ten smartwatches available in the market today. The discussion below will
give the idea about different kind of smartwatches and how easy it is to select them based on
individual interest [17]. We did a preliminary investigation on the specification of the existing
wearable sensors before choosing the sensor that we employed in our work.

2.1.1 Different kind of watches
Here is the list of watches used in medical field:
•

Empatica E4 and Empatica Embrace

•

Philips Family (Actiwatch 2, Actiwatch Pro and Actiwatch Spectrum Pro)

•

Fitbit Family (Ionic, Blaze and Charge 2)

•

Act Trust and Motion Watch 8

•

Actigraph Link and Night Shift

•

Micro Motionlogger and SOMNO watch
The Empatica E4 is reasonably well-suited watch for research when compared to other

watches. Empatica E4 acquires six different parameters and has a software dock, as well as event
marking button. It also includes, flash memory on the device and all the raw data can be easily
downloaded. However, there are many kinds of watches/devices available in the market which can
be used based on the required physiological data for research (for example, data from
accelerometer). After a preliminary investigation of available commercial watches, we found
smartwatches that are quickly adaptable for our work. Figure 1 provides a comparison of watches.
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Table 1 Comparison table for different watches
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2.2 Machine learning approaches
In today's world of complex and diverse data ranges, classification becomes quite a tedious
job on a group of sample space. Machine Learning models, ease classification of highly variant
data. There are two broad methodologies for categorizing the data into defined groups: supervised
and unsupervised learning models.

2.2.1 Supervised learning
Supervised machine learnings consist of predefined algorithms, data and its results already
initialized into the training module of the model. Later when the model is input with a new variable,
it compares with the data in the training set and accordingly the data is classified [18]. The
supervised learning model describes the input variable as predictor while the classified category
acts as the response variable. A general example of supervised learning is the model with an
equation of 𝑦 = 3𝑥 + 5, so an input 𝑥 will be mapped to the corresponding value 𝑦, where 𝑦 is
dependent, and 𝑥 is a predictor.

2.2.2 Unsupervised learning
Unsupervised learning builds its training model by learning through different inputs
without labeled responses. Unlike supervised model, the unsupervised model doesn’t have any
predefined algorithms or training set; they are left alone to devise and discover the respective
classifications from the input data. In general terms, unsupervised learning works by providing
sets of data as input and analyzing the data output; the new information is classified accordingly
[19].
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CHAPTER THREE
METHODOLOGY
In this chapter, methods used in this work are explained. We first discuss data collection
using Empatica E4. This is followed by preprocessing of data. After the completion of
preprocessing, we extracted the relevant features which will be used to develop a machine learning
algorithm. Prior to the development of machine learning model, we studied whether the relevant
features are significantly different with the drug in the system compared to no drug in the system.
The features during the no drug condition were used as a standard threshold in the machine learning
process.
An overview of machine learning approaches was presented in Chapter 2. In this chapter,
machine learning algorithms of Quadratic Support Vector Machine (SVM) and Quadratic
Discriminant are used for detecting cravings as a function of stress.

3.1 Data collection
In this work, we considered three data sets where all the participants provided the informed
consent and the study protocol was approved by the Institutional Review Board of the University
of Massachusetts Medical School:
Set 1: Opioid administration protocol (The subjects had taken opioid and it is in the system)
Patients presenting to our Emergency Department (in Worcester, MA) who are admitted to
the hospital for acute or chronic pancreatitis and have a pain management plan that includes opioid
analgesics. We had in total of 11 subjects (6 male and 5 female) with mean age of 56.5 (min: 36;
max: 77).
14

Set 2: Naloxone administration protocol (Drug withdrawal from the system)
The patients were people presenting to the Emergency Department (ED) after opioid
overdose treated with naloxone. A wearable biosensor (Empatica E4) was placed on their nondominant wrist of each participant from the time of arrival to the ED until one of three clinical
endpoints were reached: A) discharge from the ED, B) admission to the hospital, C) one-hour post
administration of a repeat dose of naloxone. Nearly 19 participants (16 male, 3 female) were
enrolled with mean age of 36.4 (min:21; max: 62).
Set 3: During treatment and recovery (cravings vs stress)
An observational trial of individuals enrolled in an intensive outpatient treatment program
for substance use disorder (SUD). Participants wore a wrist-mounted biosensor (Empatica
Embrace) on their non-dominant arms during waking hours for a four-day period. Thirty
participants were enrolled in this data collection. These subjects comprised 17 males and 13
females and had a mean age of 32.3 (min:18; max: 67).
The experiment protocol to collect physiological data in all the sets was the same. The
subjects were asked to wear the device on their wrist. Physiologic parameters were measured
continuously including heart rate, skin conductance, and skin temperature. Accelerometer data
from three axes (x, y and z). In set 3, an event marker was used to denote any time they perceived
drug craving or stress by a press of a button on the watch. The patients were given specific
information as to identify their perceived cravings as strong desire for something and stress as a
period of significant psychological distress.
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3.2 Preprocessing of data
Data obtained included some unusable values, such as out of range, empty spaces, and
NAN values. Using a simple MATLAB code, we removed these unwanted values and used the
data to extract features for machine learning.

3.3 Implementation
Preprocessed accelerometer data were analyzed, two moments of data 20 minutes before
and 20 minutes after each event marker was analyzed. In set 1, the event marker represented the
administration of opioid; in set 2, the event marker was naloxone administration, and in set 3, the
event marker represented self-reported craving or stress. The subjects in set 3, kept a separate diary
to note whether the event marker is craving or stress.
To understand how the physiologic and accelerometer features will change before and after
an event marker, a sliding window technique was used to assess the features in a five-minute
window with a four-minute overlap (four minutes of old data followed by one minute of new data).
Within each window, mean, variance, and features (shape, scale) obtained using a Hilbert
transformation [20] were estimated. The Hilbert transform is widely used signal processing tool to
estimate the predominant amplitude from a nonstationary signal. The data we obtained from the
wearable device are nonstationary and we used the Hilbert transform to estimate amplitude, which
reflects the fluctuations in data, we used Hilbert transform.
After applying the Hilbert transform, the amplitude of accelerometer data showed skew
distribution rather than a normal distribution [21], suggesting that the amplitude fluctuations were
not random. Gamma functions generally used to find the shape and scale of such a skew
distribution [21]. The scale represents the overall height of the distribution whereas the shape
16

represents the degree of skewness. This signal processing feature extraction technique included (i)
an estimation of µ (average) of the original data; (ii) variance of the original data; (iii) shape of
accelerometer data (iv) scale of the amplitude distribution obtained using Hilbert transform of the
original data and (v) the distance vector derived using shape and scale. The device has three axes
(x, y and z) and therefore we obtained five features for each axis resulting in a total of 15 features.
Gamma distribution formula is below Γ(𝑎) is given below
∞

𝚪(𝒂) = ∫ 𝒕𝒂−𝟏 𝒆−𝒕 𝒅𝒕
𝟎

(3.1)

Gamma function and gamma (x, a, B) shown below is the probability density function where a is
Shape and B is Scale.

𝒈𝒂𝒎𝒎𝒂(𝒙, 𝒂, 𝑩)
𝟏
,
= {𝑩𝒂 ɼ(𝒂)
𝟎
,

𝒙≥𝟎

(3.2)

𝒐𝒕𝒉𝒆𝒓𝒘𝒊𝒔𝒆

The mathematical expression for 𝐷𝑘 is given below where 𝛼 and 𝛽 represent the shape and scale
parameters respectively.

𝑫𝒌 = √𝜶𝟐𝒙 + 𝜷𝟐𝒙 + 𝜶𝟐𝒚 + 𝜷𝟐𝒚 + 𝜶𝟐𝒛 + 𝜷𝟐𝒛

(3.3)

3.4 Support vector machine (SVM)
In machine learning, an SVM is also called a support vector network. It is chiefly used in
supervised learning models where data can be analyzed using classification and regression. SVMs
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can separate data into two classes by both linearly and nonlinear separation functions. If the
analyzed data may be linearly separated, linear SVM is best for accuracy. In opposite, non-linear
SVM maps the input vectors to a high-dimension feature space [22].

3.4.1 Linear support vector machine
Figure 2 represents Linear SVM, where the linear equation separates two groups 𝑤𝑥 +𝑏 =
0 called the optimal plane. If a new value is given to the function f then, based on the values of
𝑤𝑥 +𝑏, appropriate classification for that value is determined. If the value of 𝑤𝑥 +𝑏 > 0 then it
falls into group A and if the value of 𝑤𝑥 +𝑏 < 0 then it falls in to group B.

Figure 1. Linear SVM [23]
In figure 3, the line passing through the boundary points 𝑥 − and 𝑥 + are called support
vectors. To get accurate results then the Margin width should be maximum, and it is calculated by
the formula M shown in the figure 3.
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Figure 2. Margin width for linear SVM [23]

3.4.2 Non-linear SVM
As our data sets are not linearly separable, then we had to map data to higher-dimensional
plane considering Non-Linear SVM.

Figure 3. Non-linear SVM [24]
In figure 4, ϕ(x) is feature space representation; this optimal plane mapped to higher
dimensional space with which we can classify between two groups. The method implemented by
kernel trick [25]. It plays the role of dot produced in the feature space. The kernel basis function
−|𝑥−𝑦|2

of Gaussian SVM is given by 𝐾(𝑥, 𝑦) = 𝑒𝑥𝑝 (

2𝜎2
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); here 𝑥 and 𝑦 are the feature vectors and

𝜎 is a, free parameter. In this process SVM, defines hyperplane in the feature space and classifies
points in that space [26].

3.5 Quadratic discriminant
Quadratic discriminant analysis (QDA) is one of the best standard tools for supervised
classification of data. The only difference between linear discriminant analysis (LDA) and QDA
is it estimates separate variance/covariance for each class. It is one of the simplest and mostflexible approaches since the number of its parameters scales quadratically with the number of its
variables.

Figure 4. Comparison of LDA and QDA [27]
It models the likelihood of each class is a Gaussian distribution and then uses posterior
distributions, explains many different approaches for quadratic discriminant analysis. One of the
criteria is to reduce the data dimensionality before estimating the Gaussian distribution, and its
formula given below; has also explained how Bayesian can yield one result if standard deviation
and variance is solved differently with the equation below [28].
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Figure 5 is the comparison of LDA and QDA, where the Black dotted line is LDA boundary,
Purple dashed line is Bayes’s boundary, Green solid line is QDA boundary. QDA fits better, in
comparison, Left X1 is best fit for LDA as it has the same variances for both of the classes, but it
is different for Right X2 as their variance for both types is not identical.
In machine learning model, we used both the models mentioned above are working
collectively to detect the difference between the cravings and stress.

3.6 Performance metrics for classifiers
After building a model in Machine Learning using extracted features, we need to check
how effective the model detects on test subjects. To monitor the performance of it, we need to
determine classification performance by metric such as classification accuracy, Log-Loss,
Receiver Operating Curve (ROC) or Area Under the Curve (AUC), and Confusion Matrix. In this
work, we assessed the effectiveness of our classifier by ROC and Confusion Matrix [29].

3.6.1 Confusion matrix
The confusion matrix is form of a matrix and gives the complete performance of the model
by providing the correctness and accuracy of the model. The classification matrix can be more
than two classes (i.e., some predictors and right classes can be more than two). To understand the
confusion matrix, we need to look at True Positive(TP), True Negative(TN), False Positive(FP)
and False Negative (FN). Figure 6, below illustrates the concept of a confusion matrix.
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Positive

True Positive

False Negative

Negative

Predicted Class

Actual Class
Positive
Negative

False Positive

True Negative

Figure 5. Confusion matrix
•

True Positive:
o It is a True Positive if the actual class of the model is True and predicted class is
also True. The model has predicted correctly.

•

True Negative:
o If the actual class of the model is False and predicted class of the model is False,
we call this result a True Negative. The model has predicted correctly.

•

False Positive:
o If the actual class of the model is False and predicted of the model is True, we call
it a False Positive. The model has mispredicted.

•

False Negative:
o if the actual class of the model is True and predicted of the model say False, then
we call it a False Negative. The model has mispredicted.

3.6.2 Classification accuracy
Accuracy can be given by the correct predictions (True Positive and True Negative) to the
total number of samples (TP, TN, FN, FP). It is the values of leading diagonal amounts to the total
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number of samples. The figure 7 and formula below gives the mathematical expression for
accuracy.
Accuracy=(TP+TN)/ (TP+FP+TN+FN)

Positive

Negative

Positive

True Positive

False Negative

Negative

Predicted Class

Actual Class

False Positive

True Negative

Figure 6. Explanation of accuracy calculation

3.6.3 Receiver operating curve (ROC)
Area Under the Curve (AUC) is one of the most widely used metrics for evaluating binary
classification models. To know more about AUC, we need to understand two terms:
•

True Positive Rate (Sensitivity): defined as TP/ (FN+TP). True Positive Rate corresponds
to the proportion of positive data observations correctly considered as positive, concerning
all positive data observations.

•

False Positive Rate (Specificity): False Positive Rate is FP / (FP+TN). False Positive Rate
corresponds to the proportion of negative data samples that are considered mistakenly as
positive, concerning all negative data samples.
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Both, the False Positive Rate (FPR) and the True Positive Rate (TPR) have values in the range [0,
1]. An AUC curve is drawn by varying the discrimination threshold and finding its corresponding
FPR and TPR. Figure 8 below, shows the example of AUC threshold values such as (0.00, 0.02,
0.04, …., 1.00). AUC is the area under the curve of plot False Positive Rate vs. True Positive Rate
at different points in [0, 1] and the measured area is 0.79.

Figure 7. Plot of ROC with different thresholds [30]
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CHAPTER FOUR
IMPLEMENTATION AND RESULTS
In this chapter, we will explain three different approaches to understand the biosensor
profile in an individual with an opioid in the system and during opioid withdrawal with naloxone
as antidote from the system. Therefore, we studied the features of the opioid in the system and
removal from the system. This analysis provided us an idea of how characteristics will change,
and we used that knowledge to differentiate cravings from stress. As defined in Chapter 3, in
section 3.3: Implementation, we followed the same procedure for the analysis and to extract the
relevant features like mean, variance, shape, scale and 𝐷𝑘 , the vector distance measure using shape
and scale.

4.1 Analysis of opioid drug administration
Based on the previous work done by S. Carreiro et al. [21], we applied sliding window
approach on the data received from nine participants (target accrual: N=40) reported chronic opioid
use when admitted to the hospital for acute exacerbation of pain. The opioid administration was
documented in the Medication Administration Record and by participants pressing the eventmarking button.

Figure 8. X-axis data for single participant
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After applying the Hilbert transform method to biometric data to identify the characteristics
of the biosensor recorded data patterns pre- and post- opioid administrations. Figure 8 shows xaxis data for single participant, the opioid administration at t=100 minutes. The top picture is the
actual raw data and below subplot is the rapid fluctuations (amplitudes) after applying Hilbert
transform. Figure 9 shows the average of the shape parameter after applying the gamma
distribution to the amplitude distribution. As presented in the figure, there is a significant change
in the shape parameter after opioid administration t=100 minutes indicating that the opioid
influences the accelerometer amplitude distribution.

Figure 9. Distribution of average shape parameter for x-axis accelerometry data
After understanding the biosensor profile of the effects of opioid administration, we
analyzed 131 opioid administration events on nine participants to differentiate between heavy and
non- heavy users using the standard statistical analysis (t-test). Opioid administration consistently
produced a striking decrease in the shape parameter in the x-axis in the 30min following
administration. This pattern persisted across repeat dosing, and chronic opioid users demonstrate
a specific reduction in short amplitude movements not present in opioid-naive individuals.
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Among the nine participants, the results of the statistical analysis to differentiate between
heavy and non-heavy user based on change in shape parameter shown in Table 2. Based on the
features we could detect all the three heavy users; however, we could detect only five non-heavy
users out of six.
Table 2 Comparison of clinical data vs. biometric data between heavy and non-heavy user

4.2 Analysis of naloxone (antidote to opioid)
As opioid abuse is rapidly escalating in the United States, and opioid reversal naloxone is
efficiently used. The administration and the effect of the drug (Naloxone) does not last long as its
actions last up to 90 minutes. To understand the biometric impacts of this antidote, we calculated
the characteristic parameters of the distribution 30 minutes before and after the N90 (drug wears
off after 90 minutes, it is like an event marking). In this analysis, we analyzed accelerometer along
with other parameters at N90 like Heart Rate (HR), Electrodermal Activity (EDA) and
Temperature. During this analysis, there were in a total of 11 active participants with the mean
average age of 36 years (min:23; max:50). A similar approach applied at the N90 mark, but to
understand and evaluate at the 90-minute post-naloxone time point. We have introduced a new
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feature 𝐷𝑘 , a six-dimensional hypothetical space with two measures, shape and scale for each of
the three axes.
We determined time N90 (marked as time = 0 and a green vertical line) based on
documented time of naloxone administration and applied Hilbert transform to obtain the amplitude
for each of the axes separately. Prior to applying Hilbert transform, we subtracted the mean from
the raw data. Figure 11 represents the amplitude calculated for each of the axes from a 5-minute
segment before (yellow shading on Figure 10) and after (green shading on Figure 10).

Figure 10. Accelerometer data from three axes XYZ from one of the subjects. The green line
marked at time =0 represents N90. The yellow and green shading represents a representative 5
minutes window before and after N90 respectively.
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After applying the Hilbert Transform at N90, we found that the amplitude follows the
widespread tail distribution and by using Gamma probability density function (pdf) we discovered
that there is a change in their shape. Figure 12 the amplitude estimation using the Hilbert transfrom
for one of the 5-minute windows is depicted.

Figure 11. Amplitude estimated using Hilbert transform for the 5 minutes window. Left panels
with blue lines represents before and right panel with red lines represents after
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We did investigate whether the fluctuations observed in these measures are significantly
different between before and after in each of the 11 participants. Table 3 shows such analysis. In
seven of the participants, we found that some of the measures are significantly different between
before (blue) and after (red). The red asterisk in Table 3 means the subject is significantly different
between before and after.
Table 3 Mean and standard deviation (SD) for 𝑫𝒌 , HR, EDA, and skin temperature for
all participants

Subjects
mean

Dk
SD

mean

SD

Heart Rate
mean
SD

1

19.36

3.26

13.51*

5.37

86.20

2

13.92

7.67

11.95

2.99

116.82

3

10.08

5.05

7.48 *

4.41

4

12.75

2.17

14.42

6.94

5

13.71

4.64

6.04 *

6

12.19

4.83

7

16.26

8
9

mean

SD

2.38

85.48

3.13

4.12

108.10*

4.85

81.09

3.47

78.66*

1.40

80.30

2.77

79.91

8.81

3.95

92.42

19.93

77.39 *

1.49

8.95 *

3.09

118.51

20.61

115.05

15.31

5.56

10.85*

2.58

90.60

11.31

80.60 *

9.91

15.04

6.80

8.18 *

3.55

93.21

6.85

94.19

3.34

19.59

3.94

19.82

3.12

94.15

12.37

76.95 *

5.61

10

11.86

9.33

14.91

7.46

106.63

7.03

93.80 *

10.60

11

16.50

6.90

20.91 *

3.90

98.61

3.27

95.89 *

4.38

mean

EDA
SD

mean

SD

Temperature
mean
SD

mean

SD

1

0.17

0.03

0.23 *

0.03

36.31

0.63

36.92 *

0.33

2

0.23

0.26

0.23

0.09

35.53

0.23

35.64 *

0.20

3

0.01

0.00

0.01

0.00

32.15

0.33

33.41 *

0.62

4

0.45

0.03

0.49 *

0.02

38.93

0.14

38.98

0.46

5

0.17

0.04

0.48 *

0.15

31.32

0.44

33.20 *

0.53

6

1.05

0.45

0.18 *

0.19

33.52

0.70

32.97

0.45

7

1.73

1.67

0.19*

0.05

37.35

3.13

38.88 *

0.66

8

0.28

0.18

0.32

0.08

32.09

5.47

35.47 *

0.74

9

1.17

0.57

0.67 *

0.29

32.26

0.70

32.37

0.55

10

0.26

0.10

0.30

0.07

27.02

1.93

29.11 *

0.14

11

0.08

0.01

0.14 *

0.04

28.12

0.15

29.81 *

0.81

Subjects
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However, significant differences in all the measures only found in three of the participants.
Figure 12 represents the overall mean of 𝐷𝑘 , heart rate, EDA and temperature along with their
respective standard error. We found that in group comparison, 𝐷𝑘 is not significant p=0.11), heart
rate is significant (p =0.007), EDA is not significant (p =0.22) and, the temperature is significant
(p =0.01). This mixed result is not surprising due to inter participant variability that is often
observed in their response to naloxone.

20.00

120.00
Before

Before

After

After

15.00

10.00

60.00

5.00

0.00

0.00

Mean_Heart Rate

Dk
0.80

Before

After

40.00

0.40

Before

After

20.00

0.00

0.00
Mean_EDA

Mean_Temperature

Figure 12. Mean and standard error of 𝑫𝒌 , HR, EDA and Temperature values obtained
from all subjects (N=11) before and after N90
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4.3 Detection of cravings using machine learning approach
In this analysis, we are trying to detect the cravings and distinguish it from an experience
of stress. These detections help the patients who are suffering from a high rate of relapse. It is an
observational trial of individuals enrolled in an intensive outpatient treatment program for
Substance use disorder (SUD). For this analysis, raw biosensor data evaluated 20 minutes before
and after each marked event. A similar kind of approach is used even in this analysis too; a slide
window technique was used to evaluate 5-minute windows with a 4- minute overlap. Within each
window mean and variance, were calculated, and shape and scale parameters were extracted using
the Hilbert transform. The six-dimensional open space was used to characterize pre- and postevent data. First, we tested whether the features (Mean, Variance, Shape, Scale and 𝐷𝑘 from each
axis) are significantly different during stress vs baseline and cravings vs baseline. There were in
total of 145 self-reported observations (104 stress events and 41 craving events). Craving episodes
showed significantly different parameters than baseline on the y axis (p=0.00), and significantly
different parameters than stress episodes on the x (p =0.009) and y (p =0.00). In comparison with
stress and cravings episodes, all the episodes were significantly different x (p =0.00), y (p =0.003)
and z (p =0.03).
After observing the significant difference in the statistical results of stress vs. cravings, we
considered these features in machine learning for real time detection. The main idea of our research
is to support the clinicians for accurate treatment as well as patients to detect the cravings for drugs
and what causes it, allowing them to know the consequences of it in ahead of time.
With the help of 145 observations from 30 participants, we built two different models to
detect cravings along with stress. In building the model, we used 60% of the data were reserved
for constructing the models and 40% for validation.
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Using Quadratic SVM classifier as shown in the confusion matrix given in Table 4, we
were able to detect 32 stress episodes out of 42 whereas we could catch ten craving episodes out
of 16. The TPR (Sensitivity) is 0.84 and FPR is 0.5. We achieved an accuracy of 72.4 and AUC
of 0.70.
Table 4 Confusion matrix for Quadratic SVM for stress vs. cravings

Stress

Craving

Stress

32

10

Craving

Predicted Class

Actual Class

6

10

Using Quadratic Discriminant classifier as shown in the confusion matrix given in Table 5, we
were able to detect 30 stress episodes out of 42 whereas we could identify ten craving episodes out
of 16. The TPR (Sensitivity) is 0.83 and FPR is 0.54. We got an accuracy of 68.9% and AUC of
0.72.
Table 5 Confusion matrix for Quadratic Discriminant for stress vs. cravings

Stress

Craving

Stress

30

12

Craving

Predicted Class

Actual Class

6

10
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CHAPTER 5
DISCUSSION AND CONCLUSION

During our research, we collected data from three different areas which are interlinked.
Firstly, the analysis on opioid drug overdose helped us to understand the effect of drugs on the
human body and how it affects the addicts. Secondly, Naloxone, an antidote, explained how the
impact of the drug control and how long a remedy lasts inside the body. Finally, the analysis on
the observational trial of individuals provided a clear picture of the cause (Cravings and its effect)
for individuals with substance abuse. In total, raw accelerometer data extracted from more than 50
participants; ranging from one day to three days. Most of the work was done on accelerometer data
and extracted relevant features from it. By which, it gave us significant statistical results to
differentiate between heavy user and non-heavy user; pre- and post- administration of naloxone;
stress and cravings. In the end, we were able to build two different models Quadratic discriminant
and SVM to detect craving along with stress.

5.1 Discussion
With shape and scale parameters with six-dimensional space (𝐷𝑘 ) we were able to detect
cravings in addicted persons. The non-linear SVM is a better model for detecting stress and nonLinear Discriminant is better model for detecting cravings. The six-dimensional space (𝐷𝑘 ) has
played a key role in the detection of cravings as the accuracy has increased from 56% to 72% and
AUC curve increased from 0.53 to 0.72. The Table 6 and Table 7 provides the summary of our
findings
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Table 6 Summary table for heavy and non-heavy user
Classifier
Quadratic SVM
Quadratic Discriminant

Accuracy (%)
57.7
61.5

AUC
0.6
0.68

Table 7 Summary table for stress and cravings
Classifier
Quadratic SVM
Quadratic Discriminant

Accuracy (%)
72.4
69

AUC
0.70
0.72

In this research, fifteen features which were extracted from the accelerometer data using Empatica
E4 for the train and build different types of ML models to detect stress and cravings in real time
application given below.

Figure 13. Framework for identifying Cravings or Stress
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5.2 Limitations and future work
There were few control subjects and less objective markings of craving in controls. The
death due to addiction is increased drastically not only in young adults but, also in other adults
irrespective of age. Improvising ML approaches to detect cravings might help clinicians to identify
the root cause of substance abuse and might help them to save lives of thousands.
The designed machine learning model should be embedded into the smart wearable devices
at low cost to deploy the device to as many individuals as possible who are suffering from addiction
in the world. Apparently, the tools which we are currently being used in present medical field are
costly. Another limitation we found is that many wearable devices are not capable of proving realtime monitoring with a docking system as well as the number of parameters it can detect. The
Empatica E4 can provide additional physiological parameters such as heart rate, temperature and
electrodermal response (EDA). The further analysis should be done on different parameters like
heart rate, EDA and temperature to increase the accuracy of the detection.

5.3 Conclusion
This study demonstrates that wearable biosensors can detect physiologic parameters
consistent with opioid effect wear off naloxone administration and drug craving in individuals
during treatment for substance abuse disorder. A signal processing method, the Hilbert transform
can be applied to wearable biosensors to detect significant changes in physiology because of the
drug. The advancement in technology, machine learning approaches and development in
smartwatches can help the patients as well as the clinicians to treat them in an efficient manner.
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